Stay updated on Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.5 to v3.6.6 in the footer, indicating a new version of the site’s software; this change does not modify core content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-09-01T19:18:29.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.4 to v3.6.5, signaling a minor page update. No study content or user-facing details appear to be changed.
    Difference
    0.1%
    Check dated 2026-08-11T06:19:36.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a minor update to the page software.
    Difference
    0.1%
    Check dated 2026-07-28T05:13:48.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.2 to v3.6.3, indicating a newer version of the page. This is a routine maintenance update and does not affect study content or visible information.
    Difference
    0.1%
    Check dated 2026-07-06T16:14:52.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page's revision marker changed from v3.6.0 to v3.6.2. This indicates the page has been updated since the previous revision.
    Difference
    0.1%
    Check dated 2026-06-29T08:57:37.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    New help/navigation items were added to the study details page: How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment label formatting was adjusted and the revision tag in the footer updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T08:10:49.000Z thumbnail image

Stay in the know with updates to Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.